As the price of EpiPens increased, so too did the salaries of Mylan's executives.
The price of EpiPens has increased by 400 percent since 2007, with some patients now paying up to $700 to fill their prescriptions. Amidst these price hikes, executives at the Canonsburg, Pa.-based company saw substantial pay increases, reported NBC News.
In 2007, Mylan CEO Heather Bresch earned about $2.5 million, and by 2015 her salary hit just under $19 million, marking a 671 percent increase.
During that same period, the wholesale price of EpiPens rose from $56.64 to $317.82, representing a 461 percent increase.
Mylan's president Rajiv Malik saw his base pay increase by 11.1 percent to $1 million in 2015. Anthony Mauro, chief commercial officer of Mylan, saw his salary jump 13.6 percent to $625,000 in 2015.